An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.
YTTRIUM Y 90 IBRITUMOMAB TIUXETAN
Meaning of YTTRIUM Y 90 IBRITUMOMAB TIUXETAN in English
NCI English Dictionary of Cancer Terms. Английский словарь раковых терминов NCI(Национальный институт злокачественных новообразований). 2012